Market Activity
T2 Biosystems (TTOO) Seeks FDA Breakthrough Device Designation for Candida Auris Test Amid Growing Global Health Concerns
T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic-resistance genes, has recently submitted an application to the U.S. Food and Drug Administration (FDA) for Breakthrough Device Designation for its Candida auris test. This move comes as the company
